These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21186347)

  • 21. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs.
    Liu YP; von Eije KJ; Schopman NC; Westerink JT; ter Brake O; Haasnoot J; Berkhout B
    Mol Ther; 2009 Oct; 17(10):1712-23. PubMed ID: 19672247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A direct comparison of strategies for combinatorial RNA interference.
    Lambeth LS; Van Hateren NJ; Wilson SA; Nair V
    BMC Mol Biol; 2010 Oct; 11():77. PubMed ID: 20937117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA interference by short hairpin RNAs expressed in vertebrate cells.
    Hannon GJ; Conklin DS
    Methods Mol Biol; 2004; 257():255-66. PubMed ID: 14770011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective knockdown of multiple target genes by expressing the single transcript harbouring multi-cistronic shRNAs.
    Junn HJ; Kim JY; Seol DW
    Biochem Biophys Res Commun; 2010 Jun; 396(4):861-5. PubMed ID: 20451494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown.
    Moore CB; Guthrie EH; Huang MT; Taxman DJ
    Methods Mol Biol; 2010; 629():141-58. PubMed ID: 20387148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age.
    Silva J; Chang K; Hannon GJ; Rivas FV
    Oncogene; 2004 Nov; 23(51):8401-9. PubMed ID: 15517022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of lentivirally expressed siRNAs.
    Liu YP; Berkhout B
    Methods Mol Biol; 2013; 942():233-57. PubMed ID: 23027055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short hairpin RNAs induced RNA interference in human cells.
    Chen YC; Song C; Luo CQ
    Ai Zheng; 2003 Jun; 22(6):566-70. PubMed ID: 12948401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short hairpin activated gene silencing in mammalian cells.
    Paddison PJ; Caudy AA; Sachidanandam R; Hannon GJ
    Methods Mol Biol; 2004; 265():85-100. PubMed ID: 15103070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals.
    Xiang S; Fruehauf J; Li CJ
    Nat Biotechnol; 2006 Jun; 24(6):697-702. PubMed ID: 16699500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of duplex stability and terminal asymmetry for shRNA design.
    Matveeva OV; Kang Y; Spiridonov AN; Saetrom P; Nemtsov VA; Ogurtsov AY; Nechipurenko YD; Shabalina SA
    PLoS One; 2010 Apr; 5(4):e10180. PubMed ID: 20422034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.
    Jaiswal A; Peddinti G; Akimov Y; Wennerberg K; Kuznetsov S; Tang J; Aittokallio T
    Genome Med; 2017 Jun; 9(1):51. PubMed ID: 28569207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen.
    Oliver D; Ji H; Liu P; Gasparian A; Gardiner E; Lee S; Zenteno A; Perinskaya LO; Chen M; Buckhaults P; Broude E; Wyatt MD; Valafar H; Peña E; Shtutman M
    Sci Rep; 2017 Feb; 7():43023. PubMed ID: 28223711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules.
    Alaaeldin E; Abu Lila AS; Ando H; Fukushima M; Huang CL; Wada H; Sarhan HA; Khaled KA; Ishida T
    J Control Release; 2017 Jun; 255():210-217. PubMed ID: 28461099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An inducible system for expression and validation of the specificity of short hairpin RNA in mammalian cells.
    Ma HT; On KF; Tsang YH; Poon RY
    Nucleic Acids Res; 2007; 35(4):e22. PubMed ID: 17234679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using a Lentivirus-Based Inducible RNAi Vector to Silence a Gene.
    Chen S; Li D; Ren Z; Yu D; Ning B; Mei N; Guo L
    Methods Mol Biol; 2020; 2102():195-210. PubMed ID: 31989556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
    Gu W; Payne E; Sun S; Burgess M; McMillan NA
    Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drosophila U6 promoter-driven short hairpin RNAs effectively induce RNA interference in Schneider 2 cells.
    Wakiyama M; Matsumoto T; Yokoyama S
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1163-70. PubMed ID: 15882998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.